- Home
- IBRX vs NWL Comparison
IBRX vs NWL Comparison
Compare IBRX & NWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- NWL
- Stock Information
- Founded
- IBRX 2014
- NWL 1903
- Country
- IBRX United States
- NWL United States
- Employees
- IBRX N/A
- NWL N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- NWL Plastic Products
- Sector
- IBRX Health Care
- NWL Industrials
- Exchange
- IBRX Nasdaq
- NWL Nasdaq
- Market Cap
- IBRX 2.3B
- NWL 2.2B
- IPO Year
- IBRX N/A
- NWL N/A
- Fundamental
- Price
- IBRX $2.53
- NWL $5.20
- Analyst Decision
- IBRX Strong Buy
- NWL Buy
- Analyst Count
- IBRX 6
- NWL 8
- Target Price
- IBRX $9.83
- NWL $7.31
- AVG Volume (30 Days)
- IBRX 10.3M
- NWL 6.4M
- Earning Date
- IBRX 11-11-2025
- NWL 10-31-2025
- Dividend Yield
- IBRX N/A
- NWL 5.39%
- EPS Growth
- IBRX N/A
- NWL N/A
- EPS
- IBRX N/A
- NWL N/A
- Revenue
- IBRX $56,600,000.00
- NWL $7,397,000,000.00
- Revenue This Year
- IBRX $629.94
- NWL N/A
- Revenue Next Year
- IBRX $109.91
- NWL $1.29
- P/E Ratio
- IBRX N/A
- NWL N/A
- Revenue Growth
- IBRX 4227.22
- NWL N/A
- 52 Week Low
- IBRX $1.83
- NWL $4.22
- 52 Week High
- IBRX $7.48
- NWL $11.78
- Technical
- Relative Strength Index (RSI)
- IBRX 47.77
- NWL 41.64
- Support Level
- IBRX $2.42
- NWL $5.10
- Resistance Level
- IBRX $2.75
- NWL $5.56
- Average True Range (ATR)
- IBRX 0.13
- NWL 0.22
- MACD
- IBRX -0.01
- NWL -0.03
- Stochastic Oscillator
- IBRX 22.88
- NWL 26.56
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
About NWL Newell Brands Inc.
Newell Brands Inc is an American consumer goods company with a portfolio of brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.